HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Haluzík Selected Research

JMV4208

8/2014Triazole GHS-R1a antagonists JMV4208 and JMV3002 attenuate food intake, body weight, and adipose tissue mass in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Haluzík Research Topics

Disease

31Obesity
12/2019 - 01/2004
21Insulin Resistance
01/2014 - 02/2001
18Type 2 Diabetes Mellitus (MODY)
12/2019 - 01/2006
18Body Weight (Weight, Body)
06/2015 - 05/2000
11Anorexia Nervosa
01/2012 - 05/2000
6Neoplasms (Cancer)
01/2016 - 01/2000
6Weight Loss (Weight Reduction)
01/2014 - 01/2005
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 01/2009
4Inflammation (Inflammations)
03/2014 - 04/2007
4Osteoarthritis
01/2012 - 09/2006
4Critical Illness (Critically Ill)
01/2008 - 09/2006
3Rheumatoid Arthritis
01/2012 - 09/2006
3Anemia
01/2010 - 01/2000
3Cushing Syndrome
01/2010 - 01/2006
3Chronic Kidney Failure (Chronic Renal Failure)
12/2005 - 01/2003
2Gestational Diabetes (Gestational Diabetes Mellitus)
10/2019 - 11/2018
2Hyperinsulinism (Hyperinsulinemia)
01/2016 - 01/2011
2Hyperaldosteronism (Conn Syndrome)
01/2016 - 01/2002
2Morbid Obesity
01/2014 - 11/2007
2Weight Gain
12/2013 - 05/2000
2Sepsis (Septicemia)
01/2012 - 01/2001
2Hypoglycemia (Reactive Hypoglycemia)
04/2011 - 01/2010
2Anorexia
01/2010 - 01/2005
2Metabolic Diseases (Metabolic Disease)
01/2009 - 09/2006
2Hyperplasia
01/2008 - 05/2001
2Atherosclerosis
04/2007 - 01/2004
2Renal Insufficiency (Renal Failure)
12/2005 - 01/2005
2Heroin Dependence (Heroin Abuse)
01/2005 - 04/2004
2Experimental Diabetes Mellitus
01/2003 - 01/2000
1Short Bowel Syndrome
10/2019
1Coronary Disease (Coronary Heart Disease)
12/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2018
1Mitochondrial Diseases (Mitochondrial Disease)
11/2017
1Carcinoma (Carcinomatosis)
01/2016
1Ovarian Neoplasms (Ovarian Cancer)
01/2016
1Essential Hypertension
01/2016
1Adenoma (Adenomas)
01/2016
1Glucose Intolerance
01/2016

Drug/Important Bio-Agent (IBA)

24LeptinIBA
01/2012 - 01/2000
17Insulin (Novolin)FDA Link
04/2016 - 10/2000
17AdiponectinIBA
03/2010 - 01/2004
15Messenger RNA (mRNA)IBA
12/2018 - 11/2007
13Hormones (Hormone)IBA
01/2015 - 05/2000
9GhrelinIBA
08/2014 - 10/2002
8Glucose (Dextrose)FDA LinkGeneric
04/2016 - 01/2002
7fibroblast growth factor 21IBA
11/2018 - 01/2009
7ResistinIBA
01/2009 - 01/2005
6Leptin ReceptorsIBA
01/2009 - 10/2000
5CytokinesIBA
03/2014 - 01/2003
5LipidsIBA
07/2013 - 06/2000
5PPAR alphaIBA
01/2011 - 01/2006
5Insulin-Like Growth Factor I (IGF-1)IBA
01/2006 - 05/2000
4AdipokinesIBA
01/2016 - 01/2006
4Hypoglycemic Agents (Hypoglycemics)IBA
12/2013 - 01/2009
4Proteins (Proteins, Gene)FDA Link
01/2012 - 01/2005
4Blood Glucose (Blood Sugar)IBA
08/2011 - 09/2006
4Estrogens (Estrogen)FDA Link
08/2011 - 01/2000
4Triglycerides (Triacylglycerol)IBA
01/2009 - 01/2003
3Ghrelin ReceptorsIBA
08/2014 - 08/2011
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2013 - 01/2000
3Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
07/2013 - 01/2010
3Fenofibrate (CiL)FDA LinkGeneric
01/2011 - 01/2007
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2011 - 01/2000
3HDL CholesterolIBA
01/2010 - 06/2000
3Fatty Acid-Binding ProteinsIBA
01/2010 - 01/2009
3Insulin-Like Growth Factor Binding Protein 1IBA
01/2006 - 10/2002
2Interleukin-6 (Interleukin 6)IBA
01/2016 - 04/2007
2C-Reactive ProteinIBA
01/2016 - 01/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 01/2005
2Biomarkers (Surrogate Marker)IBA
01/2016 - 01/2003
2NeuropeptidesIBA
06/2015 - 01/2013
2Peptides (Polypeptides)IBA
01/2013 - 01/2009
2Glucagon-Like Peptide 1 (GLP 1)IBA
11/2011 - 04/2011
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2011 - 01/2006
2estradiol 3-benzoate (estradiol benzoate)IBA
03/2010 - 05/2001
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2010 - 01/2008
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2010 - 01/2008
2AcidsIBA
01/2009 - 05/2001
2CholesterolIBA
01/2009 - 01/2003
2Dihydroxyphenylalanine (Dopa)IBA
01/2006 - 05/2001
2Fatty Acids (Saturated Fatty Acids)IBA
01/2006 - 01/2005
2Cathartics (Purgatives)IBA
01/2005 - 01/2003
2Methadone (Dolophine)FDA LinkGeneric
01/2005 - 04/2004
2Streptozocin (Streptozotocin)FDA Link
01/2003 - 01/2000
1Insulin-Like PeptidesIBA
10/2019
1Fetuin-BIBA
11/2018
1alpha-2-HS-GlycoproteinIBA
11/2018
1insulin aspart protamine drug combination 30:70 insulin aspartIBA
04/2016
1insulin aspart drug combination insulin degludecIBA
04/2016
1ClusterinIBA
01/2016
1CollagenIBA
01/2016
1OsteopontinIBA
01/2016
1AldosteroneIBA
01/2016
1Prolactin-Releasing Hormone (Prolactin Releasing Hormone)IBA
06/2015

Therapy/Procedure

7Caloric Restriction
11/2017 - 01/2006
5Therapeutics
06/2015 - 12/2001
3Bariatric Surgery
12/2019 - 01/2016
3Gastrectomy
01/2016 - 01/2014
2Renal Dialysis (Hemodialysis)
12/2005 - 01/2005
1Parenteral Nutrition
10/2019